KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 90 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $973,000 | -1.9% | 103,508 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $992,000 | +58.0% | 101,972 | +9.0% | 0.00% | 0.0% |
| Q2 2016 | $628,000 | -13.9% | 93,568 | +14.5% | 0.00% | 0.0% |
| Q1 2016 | $729,000 | -31.5% | 81,703 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $1,064,000 | +26.8% | 80,305 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $839,000 | -68.9% | 79,646 | -19.6% | 0.00% | -66.7% |
| Q2 2015 | $2,695,000 | +45.1% | 99,060 | +63.3% | 0.00% | +50.0% |
| Q1 2015 | $1,857,000 | -28.5% | 60,669 | -12.5% | 0.00% | -33.3% |
| Q4 2014 | $2,597,000 | +6.5% | 69,374 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $2,438,000 | -16.8% | 69,783 | +10.9% | 0.00% | -25.0% |
| Q2 2014 | $2,930,000 | +321.6% | 62,936 | +179.7% | 0.00% | +300.0% |
| Q1 2014 | $695,000 | +52.7% | 22,504 | +13.4% | 0.00% | 0.0% |
| Q4 2013 | $455,000 | – | 19,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |